An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing Glioblastoma Cells
Glioblastoma (GBM, WHO grade IV) is an aggressively proliferative and invasive brain tumor that carries a poor clinical prognosis with a median survival of 9 to 12 months. In a prior phosphoproteomic study performed in the U87MG glioblastoma cell line, we identified tyrosine phosphorylation events t...
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Royal Society of Chemistry
2011
|
Online Access: | http://hdl.handle.net/1721.1/67037 https://orcid.org/0000-0002-1545-1651 https://orcid.org/0000-0002-9547-3251 |